11/15/2012

As more companies offer relatively inexpensive personal genomics tests, regulators and some in the medical community are struggling with how to help patients and clinicians use the results and prevent overreaction. The language of the debate contributes to its complexity, science writer Trevor Quirk says. "In this debate’s language, people become 'consumers,' compulsion and other emotions are co-opted by 'curiosity,' and 'information' is equated with knowledge," he writes.

Related Summaries